Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Amortization of Deferred Charges (2016 - 2026)

Rockwell Medical filings provide 10 years of Amortization of Deferred Charges readings, the most recent being $89000.0 for Q4 2025.

  • On a quarterly basis, Amortization of Deferred Charges changed 0.0% to $89000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $354000.0, a 16.9% decrease, with the full-year FY2025 number at $354000.0, down 16.9% from a year prior.
  • Amortization of Deferred Charges hit $89000.0 in Q4 2025 for Rockwell Medical, roughly flat from $89000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $831000.0 in Q4 2023 to a low of $30000.0 in Q2 2024.
  • Median Amortization of Deferred Charges over the past 5 years was $92000.0 (2021), compared with a mean of $131250.0.
  • Biggest five-year swings in Amortization of Deferred Charges: soared 793.55% in 2023 and later plummeted 89.29% in 2024.
  • Rockwell Medical's Amortization of Deferred Charges stood at $93000.0 in 2021, then changed by 0.0% to $93000.0 in 2022, then soared by 793.55% to $831000.0 in 2023, then plummeted by 89.29% to $89000.0 in 2024, then changed by 0.0% to $89000.0 in 2025.
  • The last three reported values for Amortization of Deferred Charges were $89000.0 (Q4 2025), $89000.0 (Q3 2025), and $88000.0 (Q2 2025) per Business Quant data.